ESWT is suitable for patients that have been unable to find a suitable cure for their tendonopathy or orthopaedic condition when using conventional treatment methods such as physiotherapy, painkillers and injections. 

The device passes shockwaves through the skin to the injured part of the body. The shockwaves are generated by a projectile that is propelled at high speed inside a hand-held applicator. When the applicator is placed on the surface of the skin - together with a ‘coupling medium' such as ultrasound gel - the impulses are delivered as a shockwave that spreads inside the injured part of the body as an aspherical ‘radial' wave. 

Passing radial shockwaves through the surface of the skin initiates an inflammation-like response in the injured tissue that is being treated. This prompts the body to respond naturally by increasing blood circulation, the number of blood vessels and therefore metabolism in the injured tissue. This accelerates the body's natural healing process by increasing cell generation and dissolving calcium deposits 

Patients normally experience a reduction in pain or no pain at all immediately after treatment. A dull pain may present itself a few hours later, but this normally only lasts for around a day or a little longer in rare cases. 

ESWT works by initiating an inflammation-like condition in the tissue that's being treated. The body responds by increasing the metabolic activity around the impact area which in turn accelerates the body's own healing processes. Patients are advised to use prescription-free painkillers in they experience any discomfort after treatment. However, patients should not us anti-inflammatory medicine or try to cool down the treated area because this will interfere with the body's natural healing abilities. 

Some patients emerge from treatment with no discomfort whatsoever, but we strongly recommend they refrain from intensive activities that stress the treated area for at least the next 48 hours. 

Even though the response to ESWT treatment is normally exceptionally good within the first few weeks, it may take several months before the maximum effect is achieved. If patients do not experience a pronounced improvement after 3 or 4 months, your clinician will be able to advise you on the next suitable step to take. 

Yes. Cortisone injections should not be administered during the month before treatment starts, haemorrhage tendencies and coagulation system disturbances with supporting medication, heart conditions and blood circulation disturbances, acute inflammation in the treatment area, and cancer and pregnancy.